Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 151–200 of 1,781 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07218315	Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma	recruiting	N/A	15	M.D. Anderson Cancer CenterOTHER	1	Sep 11, 2026	clinicaltrials
NCT07381075	A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma	recruiting	Phase 2	90	West China HospitalOTHER	1	Sep 11, 2026